NASDAQ:ARYA ARYA Sciences Acquisition Corp III (ARYA) Stock Price, News & Analysis → 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (From Paradigm Press) (Ad) Free ARYA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$10.77▼$11.2550-Day Range$9.91▼$11.1652-Week Range$9.82▼$25.89Volume366,228 shsAverage Volume320,123 shsMarket Capitalization$186.48 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get ARYA Sciences Acquisition Corp III alerts: Email Address Ad The Bull ReportThe AI Bottleneck No One is Talking AboutRenewable energy is growing at an impressive speed - but not fast enough. This could be one of the greatest periods for the nuclear industry ever.Click here to see who's preparing to meet these needs About ARYA Sciences Acquisition Corp IIIARYA Sciences Acquisition Corp III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.Read More Ad Porter & CompanyMy next big prediction isn’t a predictionI believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in.Click here now to sign up ARYA Stock News HeadlinesMarch 16, 2024 | msn.comArya Resources Ltd. (RBZ) Drills 3.5 Kilogram per Tonne (Kg. /t) Copper, 6.1 Kg. /t Nickel, and 0.247 Kg. /t Cobalt Over 36.5 MetersFebruary 10, 2024 | msn.comARYA Sciences Acquisition IV Announces New Financial ObligationMarch 19, 2024 | Porter & Company (Ad)My next big prediction isn’t a predictionI believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in.February 10, 2024 | markets.businessinsider.comARYA Sciences Secures Convertible Sponsor LoanFebruary 3, 2024 | msn.comARYA Sciences Acquisition IV Extends Business Combination PeriodJuly 3, 2023 | finance.yahoo.comARYA Sciences Acquisition Corp V will redeem its Class A Ordinary Shares and will not consummate an initial business combinationJuly 3, 2023 | marketwatch.comArya Sciences Acquisition to Redeem SharesSeptember 12, 2022 | finance.yahoo.comATEX Mobilizes Drill Contractor for Phase III Program and Makes Third Option Payment on ValerianoMarch 19, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.September 7, 2022 | apnews.comArisGlobal Accelerates Growth, Announces Executive EvolutionAugust 1, 2022 | seekingalpha.comON Semiconductor Corporation (ON) CEO Hassane El-Khoury on Q2 2022 Results - Earnings Call TranscriptJune 8, 2022 | nz.finance.yahoo.comAkili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating OfficerJune 2, 2022 | msn.comArya.ag acquires autonomous AI agritech player PrakshepFebruary 24, 2022 | msn.comThe Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine CompanyNovember 7, 2021 | thestreet.comTradeStation Group Strikes SPAC Deal with Quantum FinTech (QFTA)October 1, 2021 | law360.comDon't Miss It: Latham, Cravath Guide Week's Hot DealsAugust 24, 2021 | nasdaq.comJefferies Top Analysts Press the ‘Buy’ Button on These 3 StocksJuly 24, 2021 | thestreet.comCCIV Adjourns Lucid Shareholder Meeting, Urges Retail ParticipationSee More Headlines Receive ARYA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARYA Sciences Acquisition Corp III and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry Holding & Other Investment Offices Sub-IndustryN/A Current SymbolNASDAQ:ARYA CUSIPN/A CIKN/A Webwww.perceptivelife.com Phone212-284-2300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.52 Quick Ratio0.52 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.30 per share Price / Book37.20Miscellaneous Outstanding Shares16,710,000Free FloatN/AMarket Cap$186.48 million OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Adam Leo Stone (Age 42)CEO & Director Mr. Michael Seth Altman C.F.A. (Age 39)CFA, CFO & Director Mr. Konstantin Poukalov (Age 37)Chief Bus. Officer ARYA Stock Analysis - Frequently Asked Questions What other stocks do shareholders of ARYA Sciences Acquisition Corp III own? Based on aggregate information from My MarketBeat watchlists, some companies that other ARYA Sciences Acquisition Corp III investors own include Trevena (TRVN), Advanced Micro Devices (AMD), BioXcel Therapeutics (BTAI), ChromaDex (CDXC), Chimerix (CMRX), CTI BioPharma (CTIC), DRDGOLD (DRD) and When did ARYA Sciences Acquisition Corp III IPO? (ARYA) raised $125 million in an IPO on Friday, August 7th 2020. The company issued 12,500,000 shares at $10.00 per share. Jefferies and Goldman Sachs acted as the underwriters for the IPO. This page (NASDAQ:ARYA) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARYA Sciences Acquisition Corp III Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.